NEW YORK--(BUSINESS WIRE)--Lev Pharmaceuticals, Inc. (“Lev” or the “Company”) (OTCBB:LEVP.OB) today announced that Joshua Schein, Ph.D., Chief Executive Officer of Lev will present at the Piper Jaffray 19th Annual Health Care Conference, being held November 27-29 at the Pierre Hotel in New York City. Dr. Schein will present a corporate progress report, including an update on the Company’s lead product candidate, C1 inhibitor, to be marketed as Cinryze™.
